GSK Plc (GSK)
59.26
-0.26
(-0.44%)
USD |
NYSE |
Feb 23, 16:00
59.26
0.00 (0.00%)
After-Hours: 19:59
GSK Market Cap : 118.91B for Feb. 23, 2026
Market Cap Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| AstraZeneca PLC | 317.72B |
| Mereo BioPharma Group Plc | 64.01M |
| Novavax, Inc. | 1.521B |
| Biodexa Pharmaceuticals Plc | 0.9898M |
| AnaptysBio, Inc. | 1.503B |
Market Cap Related Metrics
| PE Ratio | 16.17 |
| PS Ratio | 2.824 |
| PEG Ratio | 0.123 |
| Price to Book Value | 5.398 |
| Price to Free Cash Flow | 21.31 |
| Price | 59.26 |
| Earnings Yield | 6.18% |
| PEGY Ratio | 0.1202 |
| Operating PE Ratio | 12.51 |
| Normalized PE Ratio | 14.98 |